Craft

Feng Chi Biotech

Stock Price

NT$19.4

2024-10-29

Market Capitalization

NT$298.8 M

2024-10-29

Revenue

NT$171.1 M

FY, 2024

Feng Chi Biotech Summary

Company Summary

Overview
Feng Chi Biotech (豐技生物科技股份) is a company that distributes genetic testing technologies. It offers preimplantation genetic and non-invasive prenatal testing, newborn screening, medical translational research, and other services.
Type
Public
Status
Active
Founded
2001
HQ
TW | view all locations
Website
https://www.fcbiotech.com.tw/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Taipei City HQ

    Taiwan

    No. 10-1, Shaoxing N St, Zhongzheng District

Feng Chi Biotech Financials

Summary Financials

Revenue (H1, 2025)
NT$96.0M
Gross profit (H1, 2025)
NT$50.0M
Net income (H1, 2025)
NT$8.8M
Cash (H1, 2025)
NT$13.2M
EBIT (H1, 2025)
NT$10.2M
Enterprise value
$292.3M

Footer menu